EXPLORE PD HINDUJA HOSPITAL'S INFECTION CONTROL SECRET
Healthcare Radius
|July 2024
PD Hinduja Hospital and Medical Research Centre recently invested in the digitalization of its Infection Prevention and Control (IPC) program by roping in Ibhar Technologies. Healthcare Radius interviewed Dr Camilla Rodrigues, Consultant Microbiologist, and Chairperson - Infection Control Committee, PD Hinduja Hospital, Joy Chakraborty, the hospital COO, and C Bernard, MD, Ibhar Technologies, to understand this development better. Excerpts of the interview:
-
Why are nosocomial infections an important subject today?
Dr Camilla Rodrigues: Nosocomial infections mean hospital-acquired infections. The word, 'nosocomial' comes from the 17th century word form, 'nosocome', which meant 'hospital'. These are the infections that we would ascribe to a patient getting admitted to a hospital, say for a surgery, getting an infection within the hospital, and then going back. It is something that she or he didn't anticipate at all earlier.
Joy Chakraborty: In the past, infection as a subject, remained confined to the domain of clinicians and the nurses. But today, being a hospital administrator, I can see that infections can play havoc in a hospital! When you are managing a hospital without much infection, especially in the ICU, it reduces the hospital-stay for patients. It helps patients to recover faster and also go home with a reduced bill amount. No infection is good news in terms of patient outcome.
Dr Camilla Rodrigues: Today, with the advancement of medicine, we are keeping our patients alive in ICUs for much longer. We are immune-suppressing them after transplants, during their oncology treatments, etc. And with that comes a huge burden or a great responsibility for the hospital to protect patients from nosocomial or hospital-acquired infections.
Joy Chakraborty: Sometimes these infections in the hospital can completely turn away the focus of patient care from one disease to another, leading to a new episode of sickness.
When did you start organizing Infection Prevention Week?
Joy Chakraborty: Infection Prevention Week has been a practice at PD Hinduja Hospital for more than 25 years now. It is organized every year. Since the beginning the hospital management has laid a major focus on patient safety. Our infection control efforts are driven by that belief system.
Diese Geschichte stammt aus der July 2024-Ausgabe von Healthcare Radius.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Healthcare Radius
Healthcare Radius
VENUS REMEDIES GETS DRUG APPROVALS IN VIETNAM
Venus Remedies, a fixed-dosage injectable manufacturer, has secured new marketing authorisations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam.
1 mins
December 2025
Healthcare Radius
A HEALTHIER INDIA IN THE MAKING: LEADERS DECODE THE ROAD FROM 2025 TO 2026
The collective goal is clear and unanimous: to transition from a system that primarily treats sickness to one that actively promotes lifelong health and well-being.
12 mins
December 2025
Healthcare Radius
FROM GENES TO CARE: ADVANCING CLINICAL UNDERSTANDING OF HYPOPHOSPHATASIA
From genes to care, the story of hypophosphatasia reminds us that progress in medicine isn't only about scientific discovery, it's about turning knowledge into healing.
6 mins
December 2025
Healthcare Radius
ALEMBIC PHARMA GETS USFDA NOD FOR DILTIAZEM TABLETS IN THE US
Alembic Pharmaceuticals (Alembic) Aamour announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg.
1 min
December 2025
Healthcare Radius
ZYDUS GETS USFDA APPROVAL FOR PROSTATE CANCER INJECTABLE
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial (USRLD: Lupron Injection®, 1 mg/0.2 mL).
1 min
December 2025
Healthcare Radius
SUPERHEALTH LAUNCHES HONEST SECOND OPINION FOR PATIENTS
Superhealth, a zero-wait, commission Superhealth, zerohospital network, announced the launch of \"Honest Second Opinion,\" a service that helps patients make informed decisions about their treatment plans and surgical recommendations.
1 min
December 2025
Healthcare Radius
KOTAK ALTS INVESTS RS 400MN IN MEDIVERSAL
Kotak Alternate Asset Managers (Kotak Alts), through its Kotak Life Science Fund I, which invests in early to growth-stage life sciences and healthcare businesses, has made an investment of Rs 400 million in Mediversal Healthcare.
1 min
December 2025
Healthcare Radius
INVIGA HEALTHCARE FUND ACQUIRES 21% STAKE IN FORUS HEALTH
Inviga Healthcare Fund (IHF), the private equity platform founded by Dr B. S. Ajaikumar of HCG, has acquired a 21 per cent stake in Forus Health, an ophthalmic diagnostics company whose devices have screened over 22 million patients across 75+ countries.
1 min
December 2025
Healthcare Radius
OPTIMISING MATERNITY OPS: REDUCING C-SECTION BURDEN THROUGH EVIDENCE-BASED PROTOCOLS
By building systems that support safety, documentation, and respectful care, institutions can improve outcomes, lower litigation risks, and strengthen quality scores, achieving what healthcare should truly represent: Care Through Trust.”
7 mins
December 2025
Healthcare Radius
MENTAL HEALTH CARE GOES DIGITAL WITH NEW THERAPY PLATFORM
Following the global observance and continuing the commitment to mental well-being, renowned clinical psychologist Kanika Jindal announced the launch of Harmony Therapy World, a holistic digital platform designed to bring emotional healing and psychological support to people everywhere, privately, compassionately, and without barriers.
1 min
December 2025
Listen
Translate
Change font size
